Tetramethylpyrazine Alleviates Behavioral and Psychological Symptoms of Dementia Through Facilitating Hippocampal Synaptic Plasticity in Rats With Chronic Cerebral Hypoperfusion
Open Access
- 6 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
Abstract
Behavioral and psychological symptoms of dementia (BPSD) ubiquitously disturb all patients with dementia at some point in the disease course. Although a plethora of non-pharmacological and pharmacological methods targeting the relief BPSD have been developed, the therapeutic effect is still far from ideal. Here, a rat BPSD model combining the physiological changes with mental insults was successfully established. Meanwhile, our results indicated that TMP attenuated anxious behavior using an elevated plus maze (EPM) test, ameliorated recognitive ability and sociability through a novel object recognition test (NORT) and social interaction test (SIT), and improved learning and memory impairments via a Barnes maze in rats with bilateral common carotid arteries occlusion (BCCAO) plus chronic restraint stress (CRS). Given that hippocampus chronic cerebral hypoperfusion (CCH) always causes damage to the hippocampus, and the majority of cognitive impairments, behaviors, and stress responses are associated with pathology in the hippocampus including anxiety and depression, we paid attention to investigate the role of the hippocampus in BPSD. Our results indicated that Tetramethylpyrazine (TMP) attenuated anxiety and ameliorated recognitive ability, sociability, learning, and memory impairments due to alleviating dendritic and spine deficits, and upregulating the expression of synapse-related proteins (including PSD95, SYN, GAP43, SYP) in the hippocampus. We also found that the underlying mechanism was that TMP could activate the TrkB/ERK/CREB signaling pathway to promote synaptic remodeling in vivo and in vitro. Mechanically, the present study enlarges the therapeutic scope of TMP in neurodegenerative disorders and provides basic knowledge and feasible candidates for treating BPSD, particularly for vascular dementia.Funding Information
- Wuhan Science and Technology Project
This publication has 56 references indexed in Scilit:
- Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementiaTranslational Neurodegeneration, 2013
- Ligustrazine Phosphate Ethosomes for Treatment of Alzheimer’s Disease, In Vitro and in Animal Model StudiesAAPS PharmSciTech, 2012
- Management of Neuropsychiatric Symptoms in People with DementiaCNS Drugs, 2010
- A randomized controlled trial exploring the effect of music on agitated behaviours and anxiety in older people with dementiaAging & Mental Health, 2010
- Provision of Psychopharmacological Services in Nursing HomesThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2009
- ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with DementiaNeuropsychopharmacology, 2007
- Is mood chemistry?Nature Reviews Neuroscience, 2005
- Consensus Statement on Improving the Quality of Mental Health Care in U.S. Nursing Homes: Management of Depression and Behavioral Symptoms Associated with DementiaJournal of the American Geriatrics Society, 2003
- Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate tablets†Journal of Pharmaceutical Sciences, 1997
- Animal Model of DepressionArchives of General Psychiatry, 1969